Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $31.36 USD
Change Today -0.86 / -2.67%
Volume 38.9M
As of 4:15 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Frank A. D'Amelio

Chief Financial Officer and Executive Vice President of Business Operations,Pfizer Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Frank A. D'Amelio has been the Chief Financial Officer of Pfizer Inc., since August 2007 and has also been its Executive Vice President of Business Operations since December 2010. Mr. D'Amelio has three decades of an extensive operating and financial experience. Mr. D'Amelio served as a Senior Vice President of Business Operations at Pfizer Inc., from August 2007 to December 2010. Mr. D'Amelio served as the Chief Administrative Officer and Senior Executive Vice President ...

Read Full Background

Corporate Headquarters*

235 East 42nd Street
New York, New York 10017

United States

Phone: 212-733-2323
Fax: --

Board Members Memberships*

Director, Chairman of Audit Committee and Member of Investment Committee


St. John's University
Bachelor's Degree
Saint Peter's University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,268,750

Stock Options*

Restricted Stock Awards$2,140,974
All Other Compensation$217,488
Exercised Options301,572
Exercised Options Value$6,286,417
Exercisable Options873,433
Exercisable Options Value$9,323,251
Unexercisable Options1,113,955
Unexercisable Options Value$5,532,216
Total Value of Options$21,141,884
Total Number of Options2,288,960

Total Compensation*

Total Annual Cash Compensation$2,786,238
Total Short Term Compensation$1,268,750
Other Long Term Compensation$2,358,462
Total Calculated Compensation$8,482,813
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFE:US $31.36 USD -0.86


John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Paul Bulcke B.E.Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee
Nestlé S.A.
Alan George Lafley Chairman, Chief Executive Officer, President and Member of Proxy Committee
The Procter & Gamble Company
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Alex Gorsky Chairman, Chief Executive Officer, Chairman of Executive Committee and Chairman of Finance Committee
Johnson & Johnson
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at